Actively Recruiting
Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
Led by Seattle Children's Hospital · Updated on 2026-04-24
200
Participants Needed
1
Research Sites
294 weeks
Total Duration
On this page
Sponsors
S
Seattle Children's Hospital
Lead Sponsor
A
Allen Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inflammation.
CONDITIONS
Official Title
Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Suspected diagnosis of Crohn's Disease, Ulcerative Colitis, or Indeterminate Colitis
- Age between 6 and 21 years
You will not qualify if you...
- Presence of other serious medical conditions such as neurological, liver, kidney, or systemic disease
- Pregnancy
- Abuse of tobacco, alcohol, or illicit drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seattle Children's Hospital
Seattle, Washington, United States, 98105
Actively Recruiting
Research Team
M
Mason E Nuding, BS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here